Connection
Daniel Pastula to Disease Progression
This is a "connection" page, showing publications Daniel Pastula has written about Disease Progression.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.184 |
|
|
|
-
Pastula DM, Moore DH, Bedlack RS. Creatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2012 Dec 12; 12:CD005225.
Score: 0.065
-
Pastula DM, Moore DH, Bedlack RS. Creatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD005225.
Score: 0.055
-
Pastula DM, Coffman CJ, Allen KD, Oddone EZ, Kasarskis EJ, Lindquist JH, Morgenlander JC, Norman BB, Rozear MP, Sams LA, Sabet A, Bedlack RS. Factors associated with survival in the National Registry of Veterans with ALS. Amyotroph Lateral Scler. 2009 Oct-Dec; 10(5-6):332-8.
Score: 0.052
-
Bedlack RS, Pastula DM, Hawes J, Heydt D. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. Amyotroph Lateral Scler. 2009 Aug; 10(4):210-5.
Score: 0.013